pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D
暂无分享,去创建一个
Remco | J. Goudsmit | M. Cornelissen | V. Lukashov | F. Zorgdrager | J Goudsmit | R. van den Burg | F Zorgdrager | M Cornelissen | V. Den | R van den Burg | V Lukashov | V. Lukashov | J. Goudsmit | Burg
[1] E. Karita,et al. Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. , 1997, Virology.
[2] Wei-Shau Hu,et al. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[3] Andrew Carr,et al. HIV protease inhibitors , 1996, AIDS.
[4] M. Nei,et al. MEGA: Molecular Evolutionary Genetics Analysis, Version 1.02. , 1995 .
[5] N. Shen,et al. Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arrays , 1996, Nature Medicine.
[6] E. G. Shpaer,et al. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil , 1994, Journal of virology.
[7] J. Coffin,et al. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.
[8] B. Korber,et al. The World Health Organization Global Programme on AIDS Proposal for Standardization of HIV Sequence Nomenclature , 1994 .
[9] H. Gayle,et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand , 1993, The Lancet.
[10] C. Dauguet,et al. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. , 1996, Virology.
[11] J. Goudsmit,et al. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization , 1996, Journal of virology.
[12] Brendan A. Larder,et al. Site-specific mutagenesis of AIDS virus reverse transcriptase , 1987, Nature.
[13] J. Condra,et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors , 1995, Nature.
[14] J. Sodroski,et al. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization , 1996, Journal of virology.
[15] S. Ray,et al. Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression , 1995, Journal of virology.
[16] C. Kuiken,et al. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period , 1995, Journal of virology.
[17] M. Salimans,et al. Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.
[18] A S Perelson,et al. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase , 1996, Journal of virology.
[19] J S Sinsheimer,et al. In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects , 1996, Journal of virology.
[20] J. Coffin. Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. , 1979, The Journal of general virology.
[21] W. Farmerie,et al. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. , 1996, Virology.
[22] B. Larder,et al. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. , 1992, The Journal of infectious diseases.
[23] M. Busch,et al. Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group , 1995, Journal of virology.
[24] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[25] D W Barry,et al. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Mellors,et al. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor , 1996, Journal of virology.
[27] D. Ho,et al. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] P. Sharp,et al. Recombination in HIV-1 , 1995, Nature.
[29] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[30] L. M. Mansky,et al. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.
[31] E. Holmes,et al. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Sodroski,et al. Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses , 1996, Journal of virology.
[33] H Hui,et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin , 1996, Journal of virology.
[34] Wei-Shau Hu,et al. Retroviral recombination and reverse transcription. , 1990, Science.
[35] Marianne Manchester,et al. Complete mutagenesis of the HIV-1 protease , 1989, Nature.
[36] E. Domingo,et al. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy , 1995, Journal of virology.
[37] D. Burke,et al. Genetic variants of HIV-1 in Thailand. , 1992, AIDS research and human retroviruses.
[38] D. Ho,et al. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir , 1996, Nature Medicine.
[39] N. Torre,et al. Wide distribution of two subtypes of HIV-1 in Thailand. , 1992, AIDS research and human retroviruses.
[40] M. Uhlén,et al. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden. , 1995, Virology.